IMA Life, a global leader in aseptic processing and freeze-drying solutions, supports Sharp Sterile Manufacturing as part of the recent $28 million expansion of Sharp’s facility in Lee, Massachusetts.

This strategic investment includes the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials. It marks a significant milestone in strengthening sterile manufacturing capabilities in the United States.

The technology to accelerate the delivery of critical therapies to patients worldwide

The new system integrates cutting-edge robotics, non-destructive weight checks, and a state-of-the-art lyophilizer, enabling Sharp Sterile to efficiently produce batches of up to 100,000 units. By more than doubling the site’s filling capacity, this technology will help pharmaceutical partners accelerate the delivery of critical therapies to patients worldwide.
This collaboration reflects IMA Life’s commitment to providing innovative, reliable solutions that meet the highest regulatory standards for sterile drug manufacturing. The advanced technologies are designed to ensure maximum quality, safety, and efficiency, supporting our partners in addressing the growing demand for U.S.-based aseptic fill-finish services.

IMA Life, specialist in aseptic processing and freeze-drying solutions, supports Sharp Sterile Manufacturing as part of the recent $28 million expansion of Sharp’s facility in Lee, Massachusetts. (photo: IMA)
Michele Arduini, IMA Life Managing Director, said: “We are delighted to contribute to Sharp Sterile Manufacturing’s expansion with our latest aseptic filling solutions. This project demonstrates how innovation and partnership can drive excellence in pharmaceutical manufacturing and ultimately benefit patients globally.”
IMA Life continues to lead the way in aseptic processing and freeze-drying technologies, offering tailored solutions to meet the evolving needs of the pharmaceutical industry.